Pulmonary atresia with ventricular septal defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1207OMIM:178370Q25.5
Who is this for?
Show terms as
6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pulmonary atresia with ventricular septal defect (PA-VSD), also known as pulmonary atresia with VSD or tetralogy of Fallot with pulmonary atresia, is a complex congenital heart defect in which the pulmonary valve fails to form properly, completely blocking blood flow from the right ventricle to the pulmonary artery, combined with a hole between the two lower chambers of the heart (ventricular septal defect). This condition is considered the most severe form of tetralogy of Fallot. Because blood cannot travel through the normal pulmonary artery pathway to the lungs, the body relies on alternative blood vessels called major aortopulmonary collateral arteries (MAPCAs) or a patent ductus arteriosus to supply blood to the lungs for oxygenation. The anatomy of the pulmonary blood supply is highly variable among affected individuals. Infants with PA-VSD typically present shortly after birth with cyanosis (bluish discoloration of the skin due to low oxygen levels), rapid breathing, difficulty feeding, and failure to thrive. The severity of symptoms depends largely on the source and adequacy of pulmonary blood flow. Some patients may have well-developed native pulmonary arteries, while others rely entirely on MAPCAs, which can lead to uneven blood flow distribution to the lungs. Without treatment, the condition is life-threatening. Treatment is surgical and often requires a staged approach. Initial management in neonates may include prostaglandin infusion to maintain ductal patency and ensure adequate pulmonary blood flow. Surgical interventions include placement of a modified Blalock-Taussig shunt, unifocalization of MAPCAs (connecting collateral vessels to create a unified pulmonary blood supply), VSD closure, and placement of a right ventricle-to-pulmonary artery conduit. The specific surgical strategy depends on the individual anatomy of the pulmonary arteries and collateral vessels. Long-term follow-up is essential, as patients often require multiple surgeries or catheter-based interventions throughout their lives, including conduit replacements. Outcomes have improved significantly with advances in surgical techniques, though the prognosis varies depending on the complexity of the pulmonary vascular anatomy.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pulmonary atresia with ventricular septal defect.

View clinical trials →

No actively recruiting trials found for Pulmonary atresia with ventricular septal defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pulmonary atresia with ventricular septal defect community →

Specialists

6 foundView all specialists →
AP
Alexander Y Omelchenko, PhD
Specialist
PI on 1 active trial
BP
Beatrijs Bartelds, MD, PhD
Specialist
PI on 1 active trial
GA
Gabriel Altit
Specialist
PI on 1 active trial20 Pulmonary atresia with ventricular septal defect publications
NM
Nathaniel Sznycer-Taub, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial
VM
Vasilis Babaliaros, MD
ATLANTA, GA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pulmonary atresia with ventricular septal defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pulmonary atresia with ventricular septal defectForum →

No community posts yet. Be the first to share your experience with Pulmonary atresia with ventricular septal defect.

Start the conversation →

Latest news about Pulmonary atresia with ventricular septal defect

No recent news articles for Pulmonary atresia with ventricular septal defect.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pulmonary atresia with ventricular septal defect

What is Pulmonary atresia with ventricular septal defect?

Pulmonary atresia with ventricular septal defect (PA-VSD), also known as pulmonary atresia with VSD or tetralogy of Fallot with pulmonary atresia, is a complex congenital heart defect in which the pulmonary valve fails to form properly, completely blocking blood flow from the right ventricle to the pulmonary artery, combined with a hole between the two lower chambers of the heart (ventricular septal defect). This condition is considered the most severe form of tetralogy of Fallot. Because blood cannot travel through the normal pulmonary artery pathway to the lungs, the body relies on alternati

At what age does Pulmonary atresia with ventricular septal defect typically begin?

Typical onset of Pulmonary atresia with ventricular septal defect is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Pulmonary atresia with ventricular septal defect?

6 specialists and care centers treating Pulmonary atresia with ventricular septal defect are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.